TMO Operating Cash Flow
Period ending:
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
TMO operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 7,818,000,000 | |
| 8,667,000,000 | |
| 8,406,000,000 | |
| 9,154,000,000 | |
| 9,543,000,000 | |
| 8,289,000,000 | |
| 4,973,000,000 | |
| 4,543,000,000 | |
| 4,005,000,000 | |
| 3,156,300,000 | |
| 2,816,900,000 | |
| 2,619,600,000 | |
| 2,010,700,000 | |
| 2,039,500,000 | |
| 1,691,000,000 | |
| 1,497,800,000 | |
| 1,659,200,000 | |
| 1,420,200,000 | |
| 1,483,500,000 | |
| 405,654,000 | |
| 270,913,000 | |
| 264,510,000 | |
| 216,719,000 | |
| 102,892,000 | |
| 188,401,000 | |
| 199,921,000 | |
| 337,121,000 | |
| 328,500,000 | |
| 269,000,000 | |
| 224,500,000 | |
| 194,600,000 | |
| 204,200,000 | |
| 126,700,000 | |
| 54,900,000 | |
| 23,000,000 | |
| 18,600,000 | |
| 47,600,000 |
Compare operating cash flow
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) operating cash flow
- Johnson & Johnson (JNJ) operating cash flow
- AbbVie (ABBV) operating cash flow
- UnitedHealth Group (UNH) operating cash flow
- Merck & Co. (MRK) operating cash flow
- Amgen (AMGN) operating cash flow
- Gilead Sciences (GILD) operating cash flow
- Abbott Laboratories (ABT) operating cash flow
All TMO financial metrics · TMO stock overview · How to interpret financial metrics